Clinical Trial Update: Eculizumab Therapy for Chronic Complement-Mediated Injury in Kidney Transplantation [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating eculizumab therapy for chronic complement-mediated injury in kidney transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allograft Complications
• Kidney Disease

Drugs mentioned

• Eculizumab (eculizumab)

Snippet

Sponsor: Sanjay Kulkarni | Conditions: Kidney; Complications, Allograft | Phase 1 | Status: COMPLETED | Results posted: 2019-08-12